In a study that evaluated the gene expression of this cytokine in NAFLD, there was a marked increase in TGF-β1 gene expression in patients with NASH compared with simple steatosis (P = 0.0002) (49). This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.